Literature DB >> 9546361

Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.

M Vaalamo1, M L Karjalainen-Lindsberg, P Puolakkainen, J Kere, U Saarialho-Kere.   

Abstract

Programmed expression of matrix metalloproteinases is involved in wound healing in various organs. We have previously demonstrated enhanced expression of collagenase-1, stromelysin-1, matrilysin, and tissue inhibitor of metalloproteinases (TIMP-1) in gastrointestinal ulcerations. To further define the role of matrix-degrading enzymes and their inhibitors in intestinal inflammation and ulcerations, the expression of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (HME, MMP-12), and TIMP-3 mRNAs was studied using in situ hybridization and immunohistochemistry in 38 samples representing ulcerative colitis, Crohn's disease, ischemic colitis, and normal intestine. As controls for normally healing intestinal wounds, 12 postoperative samples of rat experimental jejunal anastomoses were also examined. The colitis types studied did not essentially differ in their MMP expression. We found stromelysin-2 mRNA in laminin-5-positive and Ki-67-negative enterocytes bordering the ulcerations. HME was abundantly expressed by macrophages in the vicinity of shedding mucosal epithelium and beneath the necrotic surface of the ulcers. Collagenase-3 and TIMP-3 were expressed by fibroblast-like cells deeper in the remodeling intestinal wall. Expression for stromelysin-2 and collagenase-3 was observed in granulation tissue, but not the epithelium, of the rat anastomoses. Our results suggest a role for stromelysin-2 in epithelial migration and for metalloelastase in macrophage movement and epithelial cell shedding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9546361      PMCID: PMC1858229     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta.

Authors:  N Johansson; J Westermarck; S Leppä; L Häkkinen; L Koivisto; C López-Otín; J Peltonen; J Heino; V M Kähäri
Journal:  Cell Growth Differ       Date:  1997-02

2.  Anchoring complex components laminin-5 and type VII collagen in intestine: association with migrating and differentiating enterocytes.

Authors:  I Leivo; T Tani; L Laitinen; R Bruns; E Kivilaakso; V P Lehto; R E Burgeson; I Virtanen
Journal:  J Histochem Cytochem       Date:  1996-11       Impact factor: 2.479

3.  Role of matrix metalloproteinases in failure to re-epithelialize after corneal injury.

Authors:  M E Fini; W C Parks; W B Rinehart; M T Girard; M Matsubara; J R Cook; J A West-Mays; P M Sadow; R E Burgeson; J J Jeffrey; M B Raizman; R R Krueger; J D Zieske
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

4.  Intestinal epithelial restitution. Involvement of specific laminin isoforms and integrin laminin receptors in wound closure of a transformed model epithelium.

Authors:  M M Lotz; A Nusrat; J L Madara; R Ezzell; U M Wewer; A M Mercurio
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

5.  A major role for matrix metalloproteinases in T cell injury in the gut.

Authors:  S L Pender; S P Tickle; A J Docherty; D Howie; N C Wathen; T T MacDonald
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

6.  Murine tissue inhibitor of metalloproteinases-4 (Timp-4): cDNA isolation and expression in adult mouse tissues.

Authors:  K J Leco; S S Apte; G T Taniguchi; S P Hawkes; R Khokha; G A Schultz; D R Edwards
Journal:  FEBS Lett       Date:  1997-01-20       Impact factor: 4.124

7.  Urokinase plasminogen activator is expressed by basal keratinocytes before interstitial collagenase, stromelysin-1, and laminin-5 in experimentally induced dermatitis herpetiformis lesions.

Authors:  K Airola; T Reunala; S Salo; U K Saarialho-Kere
Journal:  J Invest Dermatol       Date:  1997-01       Impact factor: 8.551

8.  Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye.

Authors:  R N Fariss; S S Apte; B R Olsen; K Iwata; A H Milam
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

9.  Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing.

Authors:  M Madlener; C Mauch; W Conca; M Brauchle; W C Parks; S Werner
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

10.  Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A.

Authors:  A Okada; C Tomasetto; Y Lutz; J P Bellocq; M C Rio; P Basset
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

View more
  59 in total

1.  Comparable expression of matrix metalloproteinases 1 and 2 in pouchitis and ulcerative colitis.

Authors:  A Stallmach; C C Chan; K W Ecker; G Feifel; H Herbst; D Schuppan; M Zeitz
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

Review 2.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

Review 3.  Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.

Authors:  Madharasi V A Pichai; Lynnette R Ferguson
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Effects of MMP12 on cell motility and inflammation during corneal epithelial repair.

Authors:  Marie Wolf; Inna Maltseva; Selene M Clay; Peipei Pan; Abhinay Gajjala; Matilda F Chan
Journal:  Exp Eye Res       Date:  2017-04-22       Impact factor: 3.467

5.  Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.

Authors:  M T Salmela; T T MacDonald; D Black; B Irvine; T Zhuma; U Saarialho-Kere; S L F Pender
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

6.  Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment.

Authors:  Rajagopalan Bhaskaran; Mark O Palmier; Nusayba A Bagegni; Xiangyang Liang; Steven R Van Doren
Journal:  J Mol Biol       Date:  2007-10-16       Impact factor: 5.469

7.  Expression of matrix metalloproteinases 9 and 12 in actinic cheilitis.

Authors:  Athanasios K Poulopoulos; Dimitrios Andreadis; Anastasios K Markopoulos
Journal:  World J Exp Med       Date:  2013-08-20

8.  Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease.

Authors:  T Kirkegaard; A Hansen; E Bruun; J Brynskov
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Matrix Metalloproteinases Expressed in Response to Bacterial Vaginosis Disrupt the Endocervical Epithelium, Increasing Transmigration of HIV.

Authors:  Michelle D Cherne; Amy L Cole; Lisa Newberry; Mary Schmidt-Owens; Michael Deichen; Alexander M Cole
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

10.  Expression and inhibition of matrix metalloproteinase (MMP)-8, MMP-9 and MMP-12 in early colonic anastomotic repair.

Authors:  Peter-Martin Krarup; Mikkel Eld; Katja Heinemeier; Lars Nannestad Jorgensen; Mark Berner Hansen; Magnus S Ågren
Journal:  Int J Colorectal Dis       Date:  2013-04-26       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.